COVID-19 -- United States
The group, which also includes experts from the World Health Organization (WHO), based its findings on a review of randomized clinical trials and observational studies. The experts reported their findings today in a Viewpoint piece in The Lancet. [Krause PK, Fleming TR, Peto R, et al. Considerations in boosting COVID-19 vaccine immune responses https://bit.ly/3C75aAG Published online September 13, 2021 ]
Later this week, FDA advisors will discuss Pfizer-BioNTech's application for COVID-19
Read more about it at HealthMap Global Disease Alerts via http://healthmap.org/ln.php?8668802&promed&0
No comments:
Post a Comment